Volume 7; Issue 5

Main
Value in Health
Volume 7; Issue 5

Value in Health

Volume 7; Issue 5

1

Publication of Pharmacoeconomic Data Submitted to Reimbursement or Clinical Guidelines Agencies

Josephine Mauskopf, Michael Drummond

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 37 KB

english, 2004

2

Technology, Regulations, and Value in Health

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 34 KB

english, 2004

3

Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?

Hans-Georg Eichler, Sheldon X. Kong, William C. Gerth, Panagiotis Mavros, Bengt Jönsson

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 116 KB

english, 2004

4

Use of Outcomes Research in Assuring Patient Safety and Quality Care, Second Plenary Session, ISPOR 8th Annual International Meeting, Arlington, VA, USA

Mark B. McClellan

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 60 KB

english, 2004

5

Return on Investment of Different Combinations of Bupropion SR Dose and Behavioral Treatment for Smoking Cessation in a Health Care Setting: An Employer's Perspective

Harold S. Javitz, Gary E. Swan, Susan M. Zbikowski, Susan J. Curry, Timothy A. McAfee, Donna Decker, Richard Patterson, Lisa M. Jack

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 99 KB

english, 2004

6

Medical Care Costs Associated with Postmenopausal Estrogen Plus Progestogen Therapy

Robert L. Ohsfeldt, Norma I. Gavin, John M. Thorp

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 119 KB

english, 2004

7

Cost-Effectiveness of Interferon Beta-1a, Interferon Beta-1b, and Glatiramer Acetate in Newly Diagnosed Non-primary Progressive Multiple Sclerosis

Lisa A. Prosser, Karen M. Kuntz, Amit Bar-Or, Milton C. Weinstein

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 242 KB

english, 2004

8

Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model

Montserrat Vera-Llonch, Thomas E Delea, Erin Richardson, Marcia Rupnow, Amy Grogg, Gerry Oster

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 138 KB

english, 2004

9

Comparing Medications in a Therapeutic Area Using an NNT Model

J. Jaime Caro, K. Jack Ishak, Ingrid Caro, Kristen Migliaccio-Walle, Wendy S. Klittich

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 136 KB

english, 2004

10

Portfolio Theory and Cost-Effectiveness Analysis: A Further Discussion

Pedram Sendi, Maiwenn J. Al, Frans F. H. Rutten

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 143 KB

english, 2004

11

Comparison of the HUI3 with the SF-36 Preference Based SF-6D in a Clinical Trial Setting

Hind T. Hatoum, John E. Brazier, Kasem S. Akhras

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 110 KB

english, 2004

12

Systematic Assessment of Decision Models in Parkinson's Disease

Uwe Siebert, Bernhard Bornschein, Tobias Walbert, Richard C. Dodel

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 142 KB

english, 2004

13

Estimating Survival for Cost-Effectiveness Analyses: A Case Study in Atherothrombosis

J. Jaime Caro, Khajak J. Ishak, Kristen Migliaccio-Walle

Journal:

Value in Health

Année:

2004

Langue:

english

Fichier:

PDF, 148 KB

english, 2004